Published online Jan 16, 2025. doi: 10.4253/wjge.v17.i1.101233
Revised: November 21, 2024
Accepted: December 6, 2024
Published online: January 16, 2025
Processing time: 129 Days and 20.3 Hours
Recent advancements in artificial intelligence (AI) have significantly enhanced the capabilities of endoscopic-assisted diagnosis for gastrointestinal diseases. AI has shown great promise in clinical practice, particularly for diagnostic support, offering real-time insights into complex conditions such as esophageal squamous cell carcinoma.
In this study, we introduce a multimodal AI system that successfully identified and delineated a small and flat carcinoma during esophagogastroduodenoscopy, highlighting its potential for early detection of malignancies. The lesion was confirmed as high-grade squamous intraepithelial neoplasia, with pathology results supporting the AI system’s accuracy. The multimodal AI system offers an integrated solution that provides real-time, accurate diagnostic information directly within the endoscopic device interface, allowing for single-monitor use without disrupting endoscopist’s workflow.
This work underscores the transformative potential of AI to enhance endoscopic diagnosis by enabling earlier, more accurate interventions.
Core Tip: This study introduces a novel multimodal artificial intelligence system (MAIS) based on the QueryInst network for real-time detection and delineation of esophageal squamous cell carcinoma and precancerous lesions during endoscopy. Unlike traditional artificial intelligence systems, MAIS integrates directly into the endoscopic device, allowing for single-monitor use without altering the endoscopist’s workflow. This case report demonstrates its ability to accurately identify a flat esophageal lesion, which was confirmed as high-grade squamous intraepithelial neoplasia. The findings highlight potential of MAIS for improving early diagnosis and biopsy accuracy in high-risk gastrointestinal conditions such as esophageal squamous cell carcinoma.
- Citation: Zhou Y, Liu RD, Gong H, Yuan XL, Hu B, Huang ZY. Multimodal artificial intelligence system for detecting a small esophageal high-grade squamous intraepithelial neoplasia: A case report. World J Gastrointest Endosc 2025; 17(1): 101233
- URL: https://www.wjgnet.com/1948-5190/full/v17/i1/101233.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i1.101233
Artificial intelligence (AI) has developed rapidly in recent years in terms of endoscopic-assisted diagnosis of gas
A 47-year-old man was found to have a small flat mucosal esophagus lesion during esophagogastroduodenoscopy assisted by MAIS.
The patient underwent esophagogastroduodenoscopy in our hospital a health examination. A small and flat mucosal lesion in the esophagus was revealed by the esophagogastroduodenoscopy.
The patient had no history of past illness.
The patient denied any family history of malignant tumors.
His vital signs were as follows: Body temperature, 37.0 °C; blood pressure, 101/61 mmHg; heart rate, 68 beats per minute; respiratory rate, 15 breaths per minute. The patient also had clear breath sounds bilaterally. A soft, non-tender, abdomen, bowel sounds, and no hepatomegaly or splenomegaly.
Laboratory examinations were absent.
During upper endoscopy, MAIS identified a flat esophageal mucosal lesion approximately 0.5 cm in diameter 31 cm from the incisors under white-light imaging, narrow band imaging (NBI), magnified NBI, and iodine staining (Figure 1A-E). The flat lesion was slightly red under white light endoscopy and brown under NBI. After magnification, the intra
Histopathology of the specimen resected by endoscopic submucosal dissection demonstrated disordered cell polarity and nuclear atypia and enlargement, and the lesion was confirmed to be a high-grade squamous intraepithelial neoplasia measuring 3.0 mm × 2.0 mm (Figure 1F).
The esophagus lesion was removed by endoscopic submucosal dissection.
The lesion was curatively resected, and follow-up endoscopy was planned in 6 months.
It was reported that MAIS was used to detect a small flat-type ESCC and a hypopharyngeal precancerous lesion incidentally, and showed great screening potential. We here report the smallest esophageal precancerous lesion detected by MAIS in real-time during clinical endoscopy, which was confirmed to be high-grade squamous intraepithelial neoplasia. Some large prospective studies also showed that AI improved the detection rate and miss rates of early ESCC and precancerous lesions during endoscopy. However, it is challenging to detect and delineate small flat precancerous lesions in real-time with AI, which can be missed even by senior endoscopists without AI (with experience of ≥ 10000 endoscopies)[4]. If the missed lesions developed into cancer insidiously, they would lead to heavy and economic burdens for families and society[5]. The biggest advantage of MAIS was that these four imaging modalities could meet the actual needs of hospitals different level and endoscopists to facilitate easier promotion and application of the system, especially in areas with limited medical resources. However, consistent false detection by MAIS is an unavoidable problem, which might cause anxiety among endoscopists and unnecessary biopsies. We will continue optimizing the model performance and believed that MAIS would assist endoscopists in detecting more early-stage ESCCs in the future, improving patients’ prognosis.
This case highlights the significant potential of the MAIS in enhancing the detection and diagnosis of early ESCC and precancerous lesions during endoscopy. As demonstrated in this case, high-grade squamous intraepithelial neoplasia can be in real-time, and MAIS offers a reliable and integrative solution for endoscopists’ daily practices. Its ability to operate seamlessly across various imaging modalities and identify tiny lesions, often challenging even for experienced clinicians, underscores its utility in advancing early cancer detection. Despite some limitations, such as false detections, the system has the advantages in terms of accessibility and adaptability, particularly for resource-constrained settings, which make it a promising tool for broader implementation. Continued optimization of MAIS could further elevate its diagnostic accuracy, ultimately reducing the clinical and economic burden of ESCC through earlier intervention and improved prognoses. This case reaffirms the transformative role of AI-driven systems in modern medical diagnostics.
1. | Le Berre C, Sandborn WJ, Aridhi S, Devignes MD, Fournier L, Smaïl-Tabbone M, Danese S, Peyrin-Biroulet L. Application of Artificial Intelligence to Gastroenterology and Hepatology. Gastroenterology. 2020;158:76-94.e2. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 230] [Cited by in F6Publishing: 298] [Article Influence: 59.6] [Reference Citation Analysis (0)] |
2. | Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J, Arnold M. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 2022;163:649-658.e2. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 223] [Cited by in F6Publishing: 393] [Article Influence: 131.0] [Reference Citation Analysis (0)] |
3. | Fang Y, Yang SS, Wang XG, Li Y, Fang C, Shan Y, Feng B, Liu WY. Instances as Queries. IEEE/CVF International Conference on Computer Vision Workshops, ICCVW; 2021, Oct 11-17. Montreal, BC, Canada. Los Alamos: arXiv, 2021: 6890-6899. [Cited in This Article: ] |
4. | Li SW, Zhang LH, Cai Y, Zhou XB, Fu XY, Song YQ, Xu SW, Tang SP, Luo RQ, Huang Q, Yan LL, He SQ, Zhang Y, Wang J, Ge SQ, Gu BB, Peng JB, Wang Y, Fang LN, Wu WD, Ye WG, Zhu M, Luo DH, Jin XX, Yang HD, Zhou JJ, Wang ZZ, Wu JF, Qin QQ, Lu YD, Wang F, Chen YH, Chen X, Xu SJ, Tung TH, Luo CW, Ye LP, Yu HG, Mao XL. Deep learning assists detection of esophageal cancer and precursor lesions in a prospective, randomized controlled study. Sci Transl Med. 2024;16:eadk5395. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
5. | Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-263. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 72] [Cited by in F6Publishing: 1262] [Article Influence: 1262.0] [Reference Citation Analysis (0)] |